Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
The Prostate|January 1, 1989
Site-specific growth of the prostate xenograft line UCRU-PR-2M E Jelbart, P J Russell, P Russell, et al.
British Journal of Urology|May 1, 1992
Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinomaM A Rosenthal, K Cox, D Raghavan, et al.
Seminars in Oncology|February 1, 1992
Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderlyD Raghavan, J F Bishop, R Stuart-Harris, et al.
Investigational New Drugs|January 1, 1997
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancyP J Creaven, R Perez, L Pendyala, et al.
Seminars in Oncology|December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumorsP J Creaven, D Raghavan, R P Perez, et al.
The Journal of Urology|March 1, 1985
Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer?D Raghavan, B Pearson, P Duval, et al.
British Journal of Urology|August 1, 1988
Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contra-indicationD Raghavan, R Grundy, T M Greenaway, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Metastatic bladder cancer: advances in treatmentW M Stadler, T M Kuzel, D Raghavan, et al.
The Journal of Urology|September 1, 1993
Characterization of a new human bladder cancer cell line, UCRU-BL-28P J Russell, Z Palavidis, E Rozinova, et al.
The Prostate|January 1, 1987
Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinomaC van Haaften-Day, D Raghavan, P Russell, et al.
Pageof 16